دورية أكاديمية

191P Preliminary biomarker and safety results of SQZ-PBMC-HPV at RP2D in monotherapy and combination with checkpoint inhibitors in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors

التفاصيل البيبلوغرافية
العنوان: 191P Preliminary biomarker and safety results of SQZ-PBMC-HPV at RP2D in monotherapy and combination with checkpoint inhibitors in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors
المؤلفون: Jimeno, A., Miselis, N.R., Park, J.C., Jennings, J., Dhani, N., Holtick, U., Iams, W.T., Rodabaugh, K., Nair, N., Kornacker, M., Loughhead, S.M., Bernstein, H., Zwirtes, R., Ji, R.R., Warren, M., Sharei, A.
المصدر: In Immuno-Oncology and Technology December 2022 16 Supplement 1
قاعدة البيانات: ScienceDirect
الوصف
تدمد:25900188
DOI:10.1016/j.iotech.2022.100303